KRISTEN KOCH: Open Payments
NPI 1356653968 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 14 payments from 9 companies in 2025. Trend: 2023 $1,008 · 2024 $874 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Calliditas Therapeutics US Inc. | 2 | $55 |
| AKEBIA THERAPEUTICS INC | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Ardelyx, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: Filspari, Fabhalta, TARPEYO, JARDIANCE, IBSRELA, Auryxia, Vafseo, Vanrafia.
Industry payments across SC — which companies pay providers there.
